eMedicine Specialties > Physical Medicine and Rehabilitation > Stroke

Lacunar Stroke

Author: Adam B Agranoff, MD, Physiatrist and Partner, Chelsea Back Care, Chelsea Community Hospital
Coauthor(s): Edward H Wong, MB, BCh, Stroke Fellow, Department of Clinical Neurological Sciences, London Health Sciences Centre, University of Western Ontario
Contributor Information and Disclosures

Updated: Jul 16, 2008

Introduction

Background

The lacunar hypothesis proposes that (1) symptomatic lacunes present with distinctive lacunar syndromes and (2) a lacune is due to occlusion of a single deep penetrating artery generated by a specific vascular pathology. This concept is controversial because different definitions of lacunes have been used. Lacunes may be confused with other empty spaces, such as enlarged perivascular (Virchow-Robbins) spaces, in which the specific small-vessel pathology occasionally is absent. Originally, lacunes were defined pathologically, but lacunes now are diagnosed on clinical and radiological grounds. This problem is compounded by the present inability to image a single penetrating artery.1

Lacunes may be defined as small subcortical infarcts (<15 mm in diameter) in the territory of the deep penetrating arteries; lacunes may present with specific lacunar syndromes or may be asymptomatic. Unfortunately, the 5 classical lacunar syndromes and the radiologic appearances are not specific for lacunes (see History). Lacunes occur most frequently in the basal ganglia and in the internal capsule, thalamus, corona radiata, and pons.

Much of our current knowledge of lacunar strokes is due to Fisher's prior cadaveric dissection of post-mortem stroke patients. He found that most symptomatic lacunar strokes are due to the occlusion of penetrating arteries of 200-800 μ m in diameter, whereas those with smaller-diameter penetrating artery infarcts tended to be asymptomatic.

Related eMedicine topic:
Lacunar Syndromes

Related Medscape topic:
Resource Center Stroke/Cerebrovascular Disease

Pathophysiology

Lacunes are caused by occlusion of a single penetrating artery. The deep penetrating arteries are small, nonbranching end arteries (usually smaller than 500 μ m in diameter), which arise directly from much larger arteries (eg, the middle cerebral artery, anterior choroidal artery, anterior cerebral artery, posterior cerebral artery, posterior communicating artery, cerebellar arteries, basilar artery). Their small size and proximal position predispose them to the development of microatheroma and lipohyalinosis.2

Initially, lipohyalinosis was thought to be the predominant small-vessel pathology of lacunes; however, microatheroma now is thought to be the most common mechanism of arterial occlusion (or stenosis). Occasionally, atheroma in the parent artery blocks the orifice of the penetrating artery (luminal atheroma), or atheroma involves the origin of the penetrating artery (junctional atheroma).

A hemodynamic (hypoperfusion) mechanism is suggested when there is a stenosis (and not occlusion) of the penetrating artery. When no evidence of small-vessel disease is found on histologic examination, an embolic cause is assumed, either artery-to-artery embolism or cardioembolism. In one series, 25% of patients with clinical, radiologically defined lacunes had a potential cardiac cause for their strokes.

Frequency

United States

In the United States and other Western nations, lacunes account for 15-25% of all ischemic strokes. In 2 community - based studies in the United States, the annual incidence rates of lacunar strokes were 13.4 and 19.5 cases per 100,000 population.

International

Two European community-based studies found higher annual incidence rates (31.7 and 53 cases per 100,000 population). This difference in incidence rates between the US and European studies may be due in part to different definitions used in the studies.

Mortality/Morbidity

Lacunar strokes have a much more favorable prognosis than do nonlacunar strokes.3,4,5

  • The early (<30 d) survival rate for patients who have had a lacunar stroke is approximately 96-97%. This compares to an early survival rate of 85% for patients who have suffered a nonlacunar stroke.
  • The late (1 yr) survival rates are 87% and 65-70% following lacunar and nonlacunar strokes, respectively.
  • Between 70% and 80% of patients who have suffered a lacunar stroke are functionally independent at 1 year, compared with fewer than 50% of patients who have had a nonlacunar stroke.

Race

Some studies have found higher frequencies of lacunar strokes in African Americans, Mexican Americans, and Hong Kong Chinese.6

Sex

Some studies have indicated that there is a higher incidence of lacunar strokes in men.

Age

The incidence of lacunar strokes increases with age. The mean age of first lacunar stroke is approximately 65 years.

Clinical

History

Lacune-related symptoms may occur suddenly or may evolve in either a fluctuating (eg, the capsular warning syndrome) or a progressive manner.Each of the 5 classical lacunar syndromes has a symptom complex that is relatively specific to it. Occasionally, cortical infarcts and intracranial hemorrhages can mimic a lacunar syndrome.7 Cortical symptoms (eg, aphasia, neglect) and visual field defects are absent.

  • Pure motor stroke/hemiparesis
    • This is the most common (33-50%) lacunar syndrome. It consists of hemiparesis or hemiplegia that typically affects the face, arm, and leg equally; however, the face or leg can be involved to a lesser extent than other regions, and occasionally only arm or leg weakness is noted.
    • Transient sensory symptoms (but not signs) may be present.
    • Dysarthria and dysphagia also may be present.
    • The lacune is usually in the posterior limb of the internal capsule, which carries the descending corticospinal and corticobulbar tracts, or the basis pontis.
  • Ataxic hemiparesis
    • This is the second most frequent lacunar syndrome and features a combination of cerebellar and motor symptoms, including weakness and clumsiness, on the ipsilateral side of the body.
    • This lacunar syndrome usually affects the leg more than it does the arm; hence, it is known also as homolateral ataxia and crural paresis. The onset of symptoms is often over hours or days.
    • The most frequent sites of infarction are the posterior limb of the internal capsule, basis pontis, and corona radiata.
  • Dysarthria/clumsy hand
    • Although now considered to be a variant of ataxic hemiparesis, this disorder usually still is classified as a separate lacunar syndrome. The lesion is in the pons.
    • The main symptoms are dysarthria and clumsiness (ie, weakness) of the hand, which often are most prominent when the patient is writing.
  • Pure sensory stroke
    • This lacunar syndrome consists of persistent or transient numbness and/or tingling on one side of the body (eg, face, arm, leg, trunk).
    • Occasionally, patients complain of pain or burning, or of another unpleasant sensation. The infarct is usually in the thalamus.
  • Mixed sensorimotor stroke
    • With this lacunar syndrome, hemiparesis or hemiplegia is noted with ipsilateral sensory impairment.
    • The infarct is usually in the thalamus and adjacent posterior internal capsule (seemingly, in the carotid and vertebrobasilar territories).

Physical

Physical examination findings differ in each of the lacunar syndromes, as follows:

  • Pure motor stroke/hemiparesis - Hemiparesis or hemiplegia is noted, with hyperreflexia and Babinski sign; no involvement of any other system is observed.
  • Ataxic hemiparesis - A combination of pyramidal signs (eg, hemiparesis, hyperreflexia, Babinski sign) and cerebellar ataxia on the same side of the body. Lower extremities are typically more involved than are upper extremities. Nystagmus may be present.
  • Dysarthria/clumsy hand - Unilateral lower facial weakness with dysarthric speech is noted. On protrusion, the tongue may deviate to the side of facial weakness. A mild, ipsilateral hemiparesis usually is noted, but the arm is ataxic. Ipsilateral hyperreflexia and Babinski sign may be observed.
  • Pure sensory stroke - Unilateral sensory loss is observed. Although the patient may complain of weakness, no weakness is found on examination.
  • Mixed sensorimotor stroke - A combination of pyramidal signs (eg, hemiparesis, hyperreflexia, Babinski sign) is noted, as is sensory loss in the absence of any cortical signs.
  • A different system for categorization of stroke subtypes also has been developed. The Trial of ORG 10172 in Acute Stroke Treatment (TOAST) developed a classification based on etiology. This system had a high interphysician agreement rate. The 5 subtypes of ischemic stroke in the TOAST study included the following8 :
    • Large-artery atherosclerosis
    • Cardioembolism
    • Small-vessel occlusion
    • Stroke of other determined etiology
    • Stroke of undetermined etiology

Causes

The cause of lacunar infarction is occlusion of a single small penetrating artery. This occlusion may be due to microatheroma and lipohyalinosis, which are associated with hypertension, smoking, and diabetes, or may result from microembolism from the heart or carotid arteries.5,9

  • Study results initially indicated that almost all patients with lacunes have hypertension. However, later studies found hypertension in only 44-75% of patients. In the setting of chronic hypertension, the penetrating arteries, which usually are not affected by atherosclerosis, may develop microatheroma and lipohyalinosis.
  • Diabetes mellitus is well recognized as a risk factor for development of small-vessel disease throughout the body, including in the penetrating arteries.
  • Smoking is an established risk factor for lacunes.
  • Embolism (either cardioembolism or artery-to-artery embolism) traditionally was considered a rare mechanism of lacunar stroke, but a potential embolic cause is not uncommon when lacunes are defined clinicoradiologically. A potential embolic cause may be a coincidental finding only. The following treatment modalities are discussed only in passing:
    • The role of anticoagulation or carotid endarterectomy in patients with lacunes has not been fully defined.
    • Although a study showed that the benefit of endarterectomy in patients with lacunes is smaller than it is in patients with nonlacunar strokes, the procedure is superior to medical therapy.
  • Atrial fibrillation and ipsilateral carotid stenosis have a stronger association with nonlacunar infarcts.10
  • Data is less clear regarding a strong association between other risk factors and lacunar stroke, including alcohol consumption, elevated cholesterol, and history of prior of stroke.

Related Medscape topic:
CME Surgery Insight: Carotid Endarterectomy -- Which Patients to Treat and When?

More on Lacunar Stroke

Overview: Lacunar Stroke
Differential Diagnoses & Workup: Lacunar Stroke
Treatment & Medication: Lacunar Stroke
Follow-up: Lacunar Stroke
References

References

  1. Bamford JM, Warlow CP. Evolution and testing of the lacunar hypothesis. Stroke. Sep 1988;19(9):1074-82. [Medline].

  2. Brenner D, Labreuche J, Pico F, et al. The renin-angiotensin-aldosterone system in cerebral small vessel disease. J Neurol. May 2 2008;[Medline].

  3. Sacco S, Marini C, Totaro R, et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology. May 9 2006;66(9):1335-8. [Medline].

  4. Bamford J, Sandercock P, Jones L, et al. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke. May-Jun 1987;18(3):545-51. [Medline].

  5. Bejot Y, Catteau A, Caillier M, et al. Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006. A population-based study. Stroke. Apr 24 2008;[Medline].

  6. Mok VC, Wong A, Lam WW, et al. A case-controlled study of cognitive progression in Chinese lacunar stroke patients. Clin Neurol Neurosurg. May 2 2008;[Medline].

  7. Bang OY, Joo SY, Lee PH, et al. The course of patients with lacunar infarcts and a parent arterial lesion: similarities to large artery vs small artery disease. Arch Neurol. Apr 2004;61(4):514-9. [Medline][Full Text].

  8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. Jan 1993;24(1):35-41. [Medline].

  9. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke. Apr 2005;36(4):891-901. [Medline][Full Text].

  10. Inzitari D, Eliasziw M, Sharpe BL, et al. Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group. Neurology. Feb 8 2000;54(3):660-6. [Medline].

  11. Nitkunan A, Barrick TR, Charlton RA, et al. Multimodal MRI in cerebral small vessel disease. Its relationship with cognition and sensitivity to change over time. Stroke. Apr 24 2008;[Medline].

  12. Rojas JI, Zurru MC, Romano M, et al. Transesophageal echocardiography findings in lacunar stroke. J Stroke Cerebrovasc Dis. May-Jun 2008;17(3):116-20. [Medline].

  13. The National Institute of Neurological Disorders and Stroke. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. Dec 14 1995;333(24):1581-7. [Medline][Full Text].

  14. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. Sep 1 1996;94(5):1167-74. [Medline][Full Text].

  15. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. Jan 20 2000;342(3):145-53. [Medline][Full Text].

  16. Pullicino PM, Caplan LR, Hommel M, eds. Cerebral Small Artery Disease. Advances in Neurology, vol 62. New York, NY: Raven Press; 1993.

  17. Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol. Feb 1979;36(2):65-73. [Medline].

  18. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol. Dec 18 1968;12(1):1-15. [Medline].

  19. Gan R, Sacco RL, Kargman DE, et al. Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology. May 1997;48(5):1204-11. [Medline].

  20. Post-stroke Rehabilitation Guideline Panel. Post-stroke Rehabilitation. Gaithersburg, Md: Aspen Pub; 1996.

  21. Rabinstein AA. Case 5-2004: a man with slurred speech and left hemiparesis. N Engl J Med. May 20 2004;350(21):2213-4; author reply 2213-4. [Medline].

  22. Zweifler RM. Management of acute stroke. South Med J. Apr 2003;96:380-5. [Medline].

Further Reading

Keywords

lacunar stroke, lacunar infarct, lacunar infarction, lacune, ischemic stroke, small-vessel disease, hemiparesis, ataxic hemiparesis, dysarthria, clumsy hand, motor stroke, sensory stroke, sensorimotor stroke, hypertension, diabetes mellitus, embolism, cardioembolism, artery-to-artery embolism

Contributor Information and Disclosures

Author

Adam B Agranoff, MD, Physiatrist and Partner, Chelsea Back Care, Chelsea Community Hospital
Adam B Agranoff, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation and North American Spine Society
Disclosure: Nothing to disclose.

Coauthor(s)

Edward H Wong, MB, BCh, Stroke Fellow, Department of Clinical Neurological Sciences, London Health Sciences Centre, University of Western Ontario
Edward H Wong, MB, BCh is a member of the following medical societies: American Academy of Neurology and American Heart Association
Disclosure: Nothing to disclose.

Medical Editor

Robert J Kaplan, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Kansas School of Medicine and Medical Center
Robert J Kaplan, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, Association of Academic Physiatrists, International Spine Intervention Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Richard Salcido, MD, Chairman, Erdman Professor of Rehabilitation, Department of Physical Medicine and Rehabilitation, University of Pennsylvania School of Medicine
Richard Salcido, MD is a member of the following medical societies: American Academy of Pain Medicine, American Academy of Physical Medicine and Rehabilitation, American College of Physician Executives, American Medical Association, and American Paraplegia Society
Disclosure: Nothing to disclose.

CME Editor

Kelly L Allen, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Lourdes Regional Rehabilitation Center, Our Lady of Lourdes Medical Center
Disclosure: Nothing to disclose.

Chief Editor

Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers, Phoenix
Denise I Campagnolo, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neuromuscular and Electrodiagnostic Medicine, American Paraplegia Society, Association of Academic Physiatrists, and Consortium of Multiple Sclerosis Centers
Disclosure: Teva Neuroscience Honoraria Speaking and teaching; Serono-Pfizer Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.